10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

10X Genomics Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 03:40PM GMT
Release Date Price: $45.35 (-4.32%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good morning, everyone. Welcome to the 2022 Bank of America Healthcare Conference live from beautiful Las Vegas. Thanks, everybody, for being here. Good to see so many people in person again.

Our next company up presenting -- by the way, I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst. Thanks, in case you don't know me. Our next company is 10x Genomics. With us is Serge Saxonov, Co-Founder and CEO; and Justin McAnear, CFO.

Gentlemen, thank you for being here.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thanks for having us [live here].

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So when we did the -- when we did the IPO a few years ago, I mean 10x was certainly -- having been in the lab for so long, I mean, certainly, the appeal of 10x and, I think, a sense of biology sort of really spoke to the scientist in me.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot